Should I Buy ISPC? ISPC 2026 Analysis

Should You Buy iSpecimen Inc (ISPC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.340

1 Day change

2.37%

52 Week Range

3.180

Analysis Updated At

2026/01/26

iSpecimen Inc (ISPC) is not a good buy for a beginner investor with a long-term focus. The company's financial performance is significantly deteriorating, and there are no positive catalysts or trading signals to support a bullish outlook. Additionally, technical indicators and trading trends do not suggest a strong entry point.

Technical Analysis

The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 59.864, and moving averages are converging, which does not provide a clear trend. The stock is trading near its pivot level (0.359) with resistance at 0.418 and support at 0.301, indicating limited upside potential.

Options Data

Positive Catalysts

2026/01/26 01:29:59

NULL identified. No recent news or significant insider/hedge fund activity.

Neutral/Negative Catalysts

2026/01/26 01:29:59

The company's financial performance has significantly deteriorated, with a 96% YoY drop in revenue, a gross margin decline of -321.27% YoY, and a negative EPS trend. Additionally, the stock is expected to decline slightly in the short term based on candlestick pattern analysis.

Financial Performance

In Q3 2025, revenue dropped by 96% YoY to $106,592. Net income improved slightly but remains negative at -$2,780,648. EPS declined by 77.14% YoY to -0.48, and gross margin dropped significantly to -92.05%. Overall, the financials indicate a struggling company with no signs of growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data is available for ISPC.

Analyst Rating

Wall Street analysts forecast ISPC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold